These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 25048345

  • 1. Usefulness of the electrocardiogram in predicting cardiovascular mortality in asymptomatic adults with aortic stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis Study).
    Greve AM, Dalsgaard M, Bang CN, Egstrup K, Rossebø AB, Boman K, Cramariuc D, Nienaber CA, Ray S, Gohlke-Baerwolf C, Okin PM, Devereux RB, Køber L, Wachtell K.
    Am J Cardiol; 2014 Sep 01; 114(5):751-6. PubMed ID: 25048345
    [Abstract] [Full Text] [Related]

  • 2. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM, Boman K, Gohlke-Baerwolf C, Kesäniemi YA, Nienaber C, Ray S, Egstrup K, Rossebø AB, Devereux RB, Køber L, Willenheimer R, Wachtell K.
    Circulation; 2012 Jan 17; 125(2):346-53. PubMed ID: 22147903
    [Abstract] [Full Text] [Related]

  • 3. Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: the SEAS study.
    Greve AM, Bang CN, Berg RM, Egstrup K, Rossebø AB, Boman K, Nienaber CA, Ray S, Gohlke-Baerwolf C, Nielsen OW, Okin PM, Devereux RB, Køber L, Wachtell K.
    Int J Cardiol; 2015 Feb 01; 180():122-8. PubMed ID: 25438232
    [Abstract] [Full Text] [Related]

  • 4. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.
    Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi YA, Malbecq W, Nienaber CA, Ray S, Skjaerpe T, Wachtell K, Willenheimer R, SEAS Investigators.
    N Engl J Med; 2008 Sep 25; 359(13):1343-56. PubMed ID: 18765433
    [Abstract] [Full Text] [Related]

  • 5. Incidence of cancer and mortality in patients from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial.
    Green A, Ramey DR, Emneus M, Iachina M, Stavem K, Bolin K, McNally R, Busch-Sørensen M, Willenheimer R, Egstrup K, Kesäniemi YA, Ray S, Basta N, Kent C, Pedersen TR.
    Am J Cardiol; 2014 Nov 15; 114(10):1518-22. PubMed ID: 25267716
    [Abstract] [Full Text] [Related]

  • 6. Impact of QRS duration and morphology on the risk of sudden cardiac death in asymptomatic patients with aortic stenosis: the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study.
    Greve AM, Gerdts E, Boman K, Gohlke-Baerwolf C, Rossebø AB, Devereux RB, Køber L, Ray S, Willenheimer R, Wachtell K.
    J Am Coll Cardiol; 2012 Mar 27; 59(13):1142-9. PubMed ID: 22440214
    [Abstract] [Full Text] [Related]

  • 7. Hypertension in aortic stenosis: implications for left ventricular structure and cardiovascular events.
    Rieck ÅE, Cramariuc D, Boman K, Gohlke-Bärwolf C, Staal EM, Lønnebakken MT, Rossebø AB, Gerdts E.
    Hypertension; 2012 Jul 27; 60(1):90-7. PubMed ID: 22647889
    [Abstract] [Full Text] [Related]

  • 8. Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fraction.
    Jander N, Minners J, Holme I, Gerdts E, Boman K, Brudi P, Chambers JB, Egstrup K, Kesäniemi YA, Malbecq W, Nienaber CA, Ray S, Rossebø A, Pedersen TR, Skjærpe T, Willenheimer R, Wachtell K, Neumann FJ, Gohlke-Bärwolf C.
    Circulation; 2011 Mar 01; 123(8):887-95. PubMed ID: 21321152
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Stroke in patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM, Dalsgaard M, Bang CN, Egstrup K, Ray S, Boman K, Rossebø AB, Gohlke-Baerwolf C, Devereux RB, Køber L, Wachtell K.
    Stroke; 2014 Jul 01; 45(7):1939-46. PubMed ID: 24903982
    [Abstract] [Full Text] [Related]

  • 11. Left atrial size and function as predictors of new-onset of atrial fibrillation in patients with asymptomatic aortic stenosis: the simvastatin and ezetimibe in aortic stenosis study.
    Bang CN, Dalsgaard M, Greve AM, Køber L, Gohlke-Baerwolf C, Ray S, Rossebø AB, Egstrup K, Wachtell K.
    Int J Cardiol; 2013 Oct 03; 168(3):2322-7. PubMed ID: 23416018
    [Abstract] [Full Text] [Related]

  • 12. Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM, Gerdts E, Boman K, Gohlke-Baerwolf C, Rossebø AB, Nienaber CA, Ray S, Egstrup K, Pedersen TR, Køber L, Willenheimer R, Wachtell K.
    Int J Cardiol; 2013 Jun 05; 166(1):72-6. PubMed ID: 21996417
    [Abstract] [Full Text] [Related]

  • 13. Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study.
    Rossebø AB, Pedersen TR, Allen C, Boman K, Chambers J, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi VA, Malbecq W, Nienaber C, Ray S, Skjaerpe T, Wachtell K, Willenheimer R.
    Am J Cardiol; 2007 Apr 01; 99(7):970-3. PubMed ID: 17398194
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Impact of stroke volume on cardiovascular risk during progression of aortic valve stenosis.
    Lønnebakken MT, De Simone G, Saeed S, Boman K, Rossebø AB, Bahlmann E, Gohlke-Bärwolf C, Gerdts E.
    Heart; 2017 Sep 01; 103(18):1443-1448. PubMed ID: 28455295
    [Abstract] [Full Text] [Related]

  • 16. Observed and predicted reduction of ischemic cardiovascular events in the Simvastatin and Ezetimibe in Aortic Stenosis trial.
    Holme I, Boman K, Brudi P, Egstrup K, Gohlke-Baerwolf C, Kesäniemi YA, Malbecq W, Rossebø AB, Wachtell K, Willenheimer R, Pedersen TR.
    Am J Cardiol; 2010 Jun 15; 105(12):1802-8. PubMed ID: 20538134
    [Abstract] [Full Text] [Related]

  • 17. Global left ventricular load in asymptomatic aortic stenosis: covariates and prognostic implication (the SEAS trial).
    Rieck AE, Gerdts E, Lønnebakken MT, Bahlmann E, Cioffi G, Gohlke-Bärwolf C, Ray S, Cramariuc D.
    Cardiovasc Ultrasound; 2012 Nov 05; 10():43. PubMed ID: 23126645
    [Abstract] [Full Text] [Related]

  • 18. Antihypertensive Treatment With β-Blockade in Patients With Asymptomatic Aortic Stenosis and Association With Cardiovascular Events.
    Bang CN, Greve AM, Rossebø AB, Ray S, Egstrup K, Boman K, Nienaber C, Okin PM, Devereux RB, Wachtell K.
    J Am Heart Assoc; 2017 Nov 27; 6(12):. PubMed ID: 29180457
    [Abstract] [Full Text] [Related]

  • 19. Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study).
    Gerdts E, Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gohlke-Bärwolf C, Holme I, Kesäniemi YA, Malbecq W, Nienaber C, Ray S, Skjærpe T, Wachtell K, Willenheimer R.
    Am J Cardiol; 2010 Dec 01; 106(11):1634-9. PubMed ID: 21094366
    [Abstract] [Full Text] [Related]

  • 20. Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study).
    Bang CN, Greve AM, La Cour M, Boman K, Gohlke-Bärwolf C, Ray S, Pedersen T, Rossebø A, Okin PM, Devereux RB, Wachtell K.
    Am J Cardiol; 2015 Dec 15; 116(12):1840-4. PubMed ID: 26602073
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.